Medication in the Treatment of Obesity (cont.)
Authors and Editors
Author: Gayle M. Galletta, MD, FACEP, Clinical Associate Professor, Department of Emergency Medicine, University of Massachusetts.
Editor: Jerry R. Balentine, DO, FACEP
Previous contributing authors and editors:
Author: Mary L Windle, Pharm D, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Pharmacy Editor, eMedicine.com, Inc.
Kathryn L Hale, MS, PA-C, Medical Writer, eMedicine.com, Inc.
Editors: Scott H Plantz, MD, FAAEM, Research Director, Assistant Professor, Department of Emergency Medicine, Mount Sinai School of Medicine; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; Jonathan Adler, MD, Instructor, Department of Emergency Medicine, Harvard Medical School, Massachusetts General Hospital.
REFERENCES:Last Editorial Review: 3/19/2013
Allison, D.B., et al. "Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP)." Obesity. 20.2 Feb. 2012: 330-42. Epub 2011 Nov3.
Fidler, M.C., et al. "A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM trial."
J Clin Endocrinol Metab. 96.10 Oct. 2011: 3067-3077. Epub 2011 Jul27.
Gadde, K.M., et al. "Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomized, placebo-controlled, phase 3 trial."
Lancet. 377.9774 Apr. 16, 2011: 1341-1352. Epub2011 Apr8.
Gayle M. Galletta, MD, FACEP
Must Read Articles Related to Medication in the Treatment of Obesity
More than two-thirds of Americans are overweight, including at least one in five
children. Nearly one-third are obese. Obesity is on the rise in our society
...learn more >>
Patient Comments & Reviews
The eMedicineHealth doctors ask about Medication in the Treatment of Obesity: